News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
825,594 Results
Type
Article (85340)
Company Profile (630)
Press Release (739624)
Section
Business (231960)
Career Advice (4093)
Deals (39628)
Drug Delivery (107)
Drug Development (90518)
Employer Resources (192)
FDA (17916)
Job Trends (17250)
News (394876)
Policy (39599)
Tag
Academia (2974)
Africa (1264)
Alliances (56358)
Alzheimer's disease (1259)
Approvals (17834)
Arizona (212)
Artificial intelligence (96)
Asia (49065)
Australia (8632)
Bankruptcy (392)
Best Places to Work (12318)
Biotechnology (444)
C2C Services and Suppliers (95111)
California (2226)
Canada (1006)
Cancer (643)
Career advice (3500)
Cell therapy (168)
China (172)
Clinical research (70671)
Collaboration (200)
Colorado (94)
Compensation (100)
Connecticut (98)
COVID-19 (2766)
Cystic fibrosis (83)
Data (473)
Diabetes (105)
Diagnostics (6526)
Drug pricing (95)
Earnings (93575)
Employer resources (162)
Europe (112233)
Events (125239)
Executive appointments (182)
FDA (18215)
Florida (307)
Funding (187)
Gene therapy (117)
GLP-1 (635)
Government (5023)
Healthcare (20661)
Hotbed/Location (534575)
Illinois (336)
Indiana (168)
Infectious disease (2807)
Inflammatory bowel disease (105)
Interviews (805)
IPO (17500)
Job creations (5172)
Job search strategy (2850)
Kansas (100)
Layoffs (472)
Legal (10019)
Lung cancer (136)
Manufacturing (123)
Maryland (465)
Massachusetts (1890)
Medical device (14289)
Medtech (14294)
Mergers & acquisitions (21992)
Metabolic disorders (333)
Michigan (144)
Minnesota (244)
Neuroscience (1463)
New Jersey (676)
New York (678)
NextGen Class of 2024 (7625)
Non-profit (5055)
North Carolina (722)
Northern California (927)
Obesity (202)
Ohio (117)
Opinion (235)
Patents (86)
Pennsylvania (632)
People (63797)
Pharmaceutical (121)
Phase I (21694)
Phase II (30668)
Phase III (23193)
Pipeline (137)
Podcasts (78)
Policy (74)
Postmarket research (3535)
Preclinical (9791)
Radiopharmaceuticals (252)
Rare diseases (164)
Real estate (7365)
Regulatory (25692)
Research institute (2635)
Resumes & cover letters (646)
South America (1645)
Southern California (858)
Startups (4274)
Texas (298)
United States (10122)
Vaccines (587)
Washington State (291)
Weight loss (182)
Date
Today (148)
Last 7 days (635)
Last 30 days (2837)
Last 365 days (39663)
2024 (29259)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 825,594 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Lexaria Appoints Michael Shankman as Chief Financial Officer
October 1, 2024
·
4 min read
Business
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
October 1, 2024
·
8 min read
Drug Development
Eirion Therapeutics Announces Results of First-in-Human Clinical Trial Evaluating Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles
October 1, 2024
·
3 min read
FDA
Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome Treatment
October 1, 2024
·
2 min read
Drug Development
Remedy Pharmaceuticals’ Phase 3 Trial in Large Lesion Stroke Patients Demonstrates Statistically Significant Effect at One Year
October 1, 2024
·
3 min read
Business
ILiAD Biotechnologies to Participate in Upcoming Investor Conferences
October 1, 2024
·
1 min read
Business
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024
October 1, 2024
·
1 min read
FDA
Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-002 for the Treatment of Danon Disease
October 1, 2024
·
3 min read
News
GeneCentric Therapeutics Announces Publication of Clinicogenomic Results from GARNER Study in High-Risk Non-Muscle Invasive Bladder Cancer
October 1, 2024
·
3 min read
Drug Development
Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial
October 1, 2024
·
6 min read
1 of 82,560
Next